Skip Navigation

Cardiovascular Research 1999 44(1):166-175; doi:10.1016/S0008-6363(99)00194-7
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pieber, D.
Right arrow Articles by Heinemann, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pieber, D.
Right arrow Articles by Heinemann, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Pressor and mesenteric arterial hyporesponsiveness to angiotensin II is an early event in haemorrhagic hypotension in anaesthetised rats

Doris Piebera, Gabi Horinab, Andreas Sandner-Kieslingc, Thomas R. Pieberd and Akos Heinemannb,*

aDepartment of Obstetrics and Gynaecology, Auenbruggerplatz 14, A-8036 Graz, Austria
bDepartment of Experimental and Clinical Pharmacology, Universitätsplatz 4, A-8010, Graz, Austria
cDepartment of Anaesthesiology, Auenbruggerplatz 5, A-8036 Graz, Austria
dDepartment of Medicine, Auenbruggerplatz 15, A-8036 Graz, Austria

* Corresponding author. Tel.: +43-316-380-4310; fax.: +43-316-380-9645 akos.heinemann{at}kfunigraz.ac.at

Objective: Vascular responsiveness to vasoconstrictors is known to be attenuated in haemorrhagic shock. In this study we assessed the temporal development and the underlying mechanisms of haemorrhage-induced vascular hyporeactivity to pressor agents. Methods: In phenobarbital-anaesthetised rats hypotension was induced by graded haemorrhage (8 ml blood total). Sham-manipulated rats served as controls. Blood flow (BF) was recorded with ultrasonic transit time flow probes. Results: Following haemorrhage mean arterial pressure (MAP) fell by 25–45 mm Hg and was accompanied by a reduction in mesenteric BF without any alteration of mesenteric vascular conductance (VC). While pressor responses to arginine vasopressin remained unaltered, hyporesponsiveness to phenylephrine (10 nmol kg–1) developed 120–180 min after hypotension had been induced. Pressor and mesenteric constrictor responses to angiotensin II (30 pmol kg–1) became significantly blunted as early as 60 min post haemorrhage. The hypotensive effect of an angiotensin1 receptor antagonist, telmisartan (1 mg kg–1), was likewise blunted 3 h after haemorrhage. Pretreatment with the cyclooxygenase inhibitor indomethacin (10 mg kg–1) exaggerated the hypotensive reaction to haemorrhage but did not prevent the development of angiotensin II hyporesponsiveness. In contrast, the nitric oxide (NO) synthase inhibitor NG-nitro-L-arginine methyl ester (10 mg kg–1), as investigated 3 h post haemorrhage, restored the systemic pressor responses to angiotensin II and phenylephrine as well as the mesenteric constrictor responses to phenylephrine to normal level and diminished the mesenteric hyporesponsiveness to angiotensin II. Glibenclamide (20 mg kg–1), an inhibitor of ATP-sensitive K+ channels given 180 min post haemorrhage, partially reversed haemorrhage-induced hypotension but did not modify angiotensin II hyporesponsiveness. Conclusion: Systemic pressor responsiveness and mesenteric arterial reactivity to endogenous and exogenous angiotensin II is selectively impaired at an early stage of haemorrhagic hypotension. This phenomenon partially involves NO and is not related to ATP-sensitive K+ channels.

KEYWORDS BF, blood flow; L-NAME, NG-nitro-L-arginine methyl ester; MAP, mean arterial pressure; NO, nitric oxide; VC, vascular conductance


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation
Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. L. Atkins, B. W. Day, M. T. Handrigan, Z. Zhang, M. B. Pamnani, and N. V. Gorbunov
Brisk production of nitric oxide and associated formation of S-nitrosothiols in early hemorrhage
J Appl Physiol, April 1, 2006; 100(4): 1267 - 1277.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Liaudet, F. G. Soriano, E. Szabo, L. Virag, J. G. Mabley, A. L. Salzman, and C. Szabo
Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase
PNAS, August 29, 2000; 97(18): 10203 - 10208.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.